Editor’s Note: On May 27, 2023, Sheldrick posted an update on his blog that his complaint was rejected by the journal CHEST. The original post has been removed. The data underpinning an infamous study ...
Exact Sciences Corporation EXAS recently announced the online publication of the BLUE-C study results in The New England Journal of Medicine (NEJM). The 20,000-participant, multi-center and ...
Cologuard Plus is only noninvasive test to be evaluated head-to-head against an independent fecal immunochemical test, which it significantly outperformed 20,000-participant BLUE-C study included 98 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results